FUZEON DIN 02247725
Health Canada record
| Active ingredient(s) | ENFUVIRTIDE 108 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J05AX07 ENFUVIRTIDE |
| Original market date | 18-Aug-2003 |
| Current status date | 31-Mar-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Hoffmann-La Roche Limited — licence 100006, currently licensed, last inspection rating C (2024-06-25).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 538 | 2003-07-14 | New Drug Submission (NDS) |